Clinical trial
Forxiga Tablets Specific Clinical Experience Investigation for Long-term Use
NCT02200666 is registered in ClinicalTrials.gov with AstraZeneca as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Forxiga Tablets Specific Clinical Experience Investigation for Long-term Use
- Lead sponsor
- AstraZeneca
- Phase
- Observational
- Overall status
- Completed
- Start date
- October 3, 2014
- Completion date
- September 9, 2019
- Enrollment
- 7,793 (actual)
- Sites
- 47
Conditions
As the registry lists them; a condition with its own page is linked.
type 2 diabetes mellitus